Evidence map›Paper›PMID 24373971›Full record

ArticleCell reports2014

Loss of MEC-17 leads to microtubule instability and axonal degeneration.

Brent Neumann, Massimo A Hilliard

Abstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Tubulin Acetylation: A Critical Regulator of Microtubule Function.Results and problems in cell differentiation · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Disruption of axonal transport in neurodegeneration.The Journal of clinical investigation · 2023
    Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brent NeumannQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia.
Massimo A HilliardQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: m.hilliard@uq.edu.au.

Funding

Femtosecond laser axotomy for in vivo nerve regeneration studies in C elegansR01NS060129 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI BEN-YAKAR, ADELA · 2007 to 2010
$1.7M
NINDS NIH HHS R01 NS060129NINDS NIH HHS R01NS060129
6 · The paper itself

Abstract

Axonal degeneration arises as a consequence of neuronal injury and is a common hallmark of a number of neurodegenerative diseases. However, the genetic causes and the cellular mechanisms that trigger this process are still largely unknown. Based on forward genetic screening in C. elegans, we have identified the α-tubulin acetyltransferase gene mec-17 as causing spontaneous, adult-onset, and progressive axonal degeneration. Loss of MEC-17 leads to microtubule instability, a reduction in mitochondrial number, and disrupted axonal transport, with altered distribution of both mitochondria and synaptic components. Furthermore, mec-17-mediated axonal degeneration occurs independently from its acetyltransferase domain; is enhanced by mutation of coel-1, a tubulin-associated molecule; and correlates with the animal's body length. This study therefore identifies a critical role for the conserved microtubule-associated protein MEC-17 in preserving axon integrity and preventing axonal degeneration.

Indexed as

AcetyltransferasesAnimalsAxonal TransportAxonsCaenorhabditis elegansCaenorhabditis elegans ProteinsMicrotubulesMitochondriaMutationAcetyltransferasesCaenorhabditis elegans ProteinsMEC-17 protein, C elegans

Identifiers

PMID24373971
PMCPMC3939029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.